Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Oct;59(10):3651–3658. doi: 10.1128/iai.59.10.3651-3658.1991

Protection of rat intestine against cholera toxin challenge by monoclonal anti-idiotypic antibody immunization via enteral and parenteral routes.

G P Lucas 1, C L Cambiaso 1, J P Vaerman 1
PMCID: PMC258934  PMID: 1894367

Abstract

A mouse monoclonal anti-idiotypic (anti-id) immunoglobulin M (IgM) antibody, called MAb2, was raised against a mouse monoclonal anti-cholera toxin (anti-CT) antibody (MAb1). The MAb2 was shown, by competition with CT for MAb1, to bear the internal image of an epitope of CT. MAb2 immunization of rats was performed via the intraperitoneal, intragastric, and intrajejunal routes and compared with immunization of rats with either a control, isotype- and allotype-matched MAb or with CT via the same routes. Both serum IgG and bile IgA anti-CT Ab3's were detected by enzyme-linked immunosorbent assay in anti-id MAb2-immunized rats, although their titers were lower than those in CT-immunized rats. No anti-CT antibodies were detected in sera and bile of rats immunized with the control MAb. When tested for degree of gut protection against a CT challenge, rats immunized with MAb2 by the intrajejunal route showed a rather high degree of protection, which was only slightly lower than that of rats immunized with CT via the same route; all rats but one immunized with the control MAb were unprotected. There was, however, no correlation between serum or bile anti-CT titers and degree of gut protection in MAb2-immunized rats. Their serum anti-CT Ab3's were purified by adsorption and elution from a CT immunosorbent and resembled anti-CT MAb1 in their unique reactivity with MAb2. This constitutes to our knowledge the second report of protection against a pathogen by anti-id immunization via the enteric route.

Full text

PDF
3651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker M. D., Wu G. E., Toone W. M., Murialdo H., Davis A. C., Shulman M. J. A region of the immunoglobulin-mu heavy chain necessary for forming pentameric IgM. J Immunol. 1986 Sep 1;137(5):1724–1728. [PubMed] [Google Scholar]
  2. Black R. E., Levine M. M., Clements M. L., Young C. R., Svennerholm A. M., Holmgren J. Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin. Infect Immun. 1987 May;55(5):1116–1120. doi: 10.1128/iai.55.5.1116-1120.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cambiaso C. L., Leek A. E., De Steenwinkel F., Billen J., Masson P. L. Particle counting immunoassay (PACIA). I. A general method for the determination of antibodies, antigens, and haptens. J Immunol Methods. 1977;18(1-2):33–44. doi: 10.1016/0022-1759(77)90156-9. [DOI] [PubMed] [Google Scholar]
  4. Clemens J. D., Harris J. R., Sack D. A., Chakraborty J., Ahmed F., Stanton B. F., Khan M. U., Kay B. A., Huda N., Khan M. R. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis. 1988 Jul;158(1):60–69. doi: 10.1093/infdis/158.1.60. [DOI] [PubMed] [Google Scholar]
  5. Clemens J. D., Sack D. A., Harris J. R., Van Loon F., Chakraborty J., Ahmed F., Rao M. R., Khan M. R., Yunus M., Huda N. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet. 1990 Feb 3;335(8684):270–273. doi: 10.1016/0140-6736(90)90080-o. [DOI] [PubMed] [Google Scholar]
  6. Ertl H. C., Finberg R. W. Sendai virus-specific T-cell clones: induction of cytolytic T cells by an anti-idiotypic antibody directed against a helper T-cell clone. Proc Natl Acad Sci U S A. 1984 May;81(9):2850–2854. doi: 10.1073/pnas.81.9.2850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Finberg R. W., Ertl H. The use of antiidiotypic antibodies as vaccines against infectious agents. Crit Rev Immunol. 1987;7(4):269–284. [PubMed] [Google Scholar]
  8. Galfrè G., Milstein C. Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol. 1981;73(Pt B):3–46. doi: 10.1016/0076-6879(81)73054-4. [DOI] [PubMed] [Google Scholar]
  9. Grzych J. M., Capron M., Lambert P. H., Dissous C., Torres S., Capron A. An anti-idiotype vaccine against experimental schistosomiasis. Nature. 1985 Jul 4;316(6023):74–76. doi: 10.1038/316074a0. [DOI] [PubMed] [Google Scholar]
  10. Hiernaux J. R. Idiotypic vaccines and infectious diseases. Infect Immun. 1988 Jun;56(6):1407–1413. doi: 10.1128/iai.56.6.1407-1413.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jackson S., Mestecky J., Childers N. K., Michalek S. M. Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect Immun. 1990 Jun;58(6):1932–1936. doi: 10.1128/iai.58.6.1932-1936.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  13. Kaufmann S. H., Eichmann K., Müller I., Wrazel L. J. Vaccination against the intracellular bacterium Listeria monocytogenes with a clonotypic antiserum. J Immunol. 1985 Jun;134(6):4123–4127. [PubMed] [Google Scholar]
  14. Kay R. A., Ferguson A. Systemic delayed-type hypersensitivity to cholera toxin and a detoxified derivative. Clin Exp Immunol. 1989 Apr;76(1):111–116. [PMC free article] [PubMed] [Google Scholar]
  15. Kennedy R. C., Eichberg J. W., Lanford R. E., Dreesman G. R. Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science. 1986 Apr 11;232(4747):220–223. doi: 10.1126/science.3952505. [DOI] [PubMed] [Google Scholar]
  16. Kresina T. F., Olds G. R. Antiidiotypic antibody vaccine in murine Schistosomiasis mansoni comprising the internal image of antigen. J Clin Invest. 1989 Mar;83(3):912–920. doi: 10.1172/JCI113976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lange S., Holmgren J. Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C. 1978 Aug;86C(4):145–152. doi: 10.1111/j.1699-0463.1978.tb02572.x. [DOI] [PubMed] [Google Scholar]
  18. Lemaitre-Coelho I., Jackson G. D., Vaerman J. P. Relevance of biliary IgA antibodies in rat intestinal immunity. Scand J Immunol. 1978;8(5):459–463. doi: 10.1111/j.1365-3083.1978.tb00542.x. [DOI] [PubMed] [Google Scholar]
  19. Lemaître-Coelho I., Jackson G. D., Vaerman J. P. Rat bile as a convenient source of secretory IgA and free secretory component. Eur J Immunol. 1977 Aug;7(8):588–590. doi: 10.1002/eji.1830070818. [DOI] [PubMed] [Google Scholar]
  20. Lindholm L., Holmgren J., Wikström M., Karlsson U., Andersson K., Lycke N. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. Infect Immun. 1983 May;40(2):570–576. doi: 10.1128/iai.40.2.570-576.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lucas G. P., Cambiaso C. L., Vaerman J. P. Receptor binding-like specificity of two anti-cholera toxin monoclonal antibodies detected by latex agglutination immunoassay. Immunol Lett. 1989 Sep;22(3):227–234. doi: 10.1016/0165-2478(89)90196-x. [DOI] [PubMed] [Google Scholar]
  22. Lycke N., Bromander A. K., Holmgren J. Role of local IgA antitoxin-producing cells for intestinal protection against cholera toxin challenge. Int Arch Allergy Appl Immunol. 1989;88(3):273–279. doi: 10.1159/000234806. [DOI] [PubMed] [Google Scholar]
  23. Lycke N., Eriksen L., Holmgren J. Protection against cholera toxin after oral immunization is thymus-dependent and associated with intestinal production of neutralizing IgA antitoxin. Scand J Immunol. 1987 Apr;25(4):413–419. doi: 10.1111/j.1365-3083.1987.tb02208.x. [DOI] [PubMed] [Google Scholar]
  24. Lycke N., Holmgren J. Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin. Scand J Immunol. 1986 May;23(5):611–616. doi: 10.1111/j.1365-3083.1986.tb01995.x. [DOI] [PubMed] [Google Scholar]
  25. Martinez C. A., Barua D., Merson M. H. Control of diarrhoeal diseases. World Health Stat Q. 1988;41(2):74–81. [PubMed] [Google Scholar]
  26. Masson P. L., Cambiaso C. L., Collet-Cassart D., Magnusson C. G., Richards C. B., Sindic C. J. Particle counting immunoassay (PACIA). Methods Enzymol. 1981;74(Pt 100):106–139. doi: 10.1016/0076-6879(81)74008-4. [DOI] [PubMed] [Google Scholar]
  27. McNamara M. K., Ward R. E., Kohler H. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science. 1984 Dec 14;226(4680):1325–1326. doi: 10.1126/science.6505692. [DOI] [PubMed] [Google Scholar]
  28. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–276. doi: 10.1007/BF00915547. [DOI] [PubMed] [Google Scholar]
  29. Nakane P. K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974 Dec;22(12):1084–1091. doi: 10.1177/22.12.1084. [DOI] [PubMed] [Google Scholar]
  30. Pierce N. F., Cray W. C., Jr, Engel P. F. Antitoxic immunity to cholera in dogs immunized orally with cholera toxin. Infect Immun. 1980 Feb;27(2):632–637. doi: 10.1128/iai.27.2.632-637.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pierce N. F., Cray W. C., Jr, Sacci J. B., Jr Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect Immun. 1982 Aug;37(2):687–694. doi: 10.1128/iai.37.2.687-694.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pierce N. F., Cray W. C., Jr, Sircar B. K. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera. Infect Immun. 1978 Jul;21(1):185–193. doi: 10.1128/iai.21.1.185-193.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pierre P. G., Solbreux P., Vaerman J. P. Cholera toxin-induced fluid secretion in rat gut ligated loops: influence of bile from normal or cholera toxin-immunized rats. Immunology. 1989 Nov;68(3):319–324. [PMC free article] [PubMed] [Google Scholar]
  34. Pierre P., Langendries A., Vaerman J. P. Cholera toxin neutralization: a comparison of purified serum IgG and biliary secretory IgA antibodies. Immunol Lett. 1988 May;18(1):51–55. doi: 10.1016/0165-2478(88)90069-7. [DOI] [PubMed] [Google Scholar]
  35. Sacks D. L., Esser K. M., Sher A. Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies. J Exp Med. 1982 Apr 1;155(4):1108–1119. doi: 10.1084/jem.155.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Schick M. R., Dreesman G. R., Kennedy R. C. Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol. 1987 May 15;138(10):3419–3425. [PubMed] [Google Scholar]
  37. Solbreux P. M., Dive C., Vaerman J. P. Anti-cholera toxin IgA-, IgG- and IgM-secreting cells in various rat lymphoid tissues after repeated intestinal or parenteral immunizations. Immunol Invest. 1990 Oct-Dec;19(5-6):435–451. doi: 10.3109/08820139009052971. [DOI] [PubMed] [Google Scholar]
  38. Stein K. E., Söderström T. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med. 1984 Oct 1;160(4):1001–1011. doi: 10.1084/jem.160.4.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sun D. X., Mekalanos J. J., Taylor R. K. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis. 1990 Jun;161(6):1231–1236. doi: 10.1093/infdis/161.6.1231. [DOI] [PubMed] [Google Scholar]
  40. Svennerholm A. M., Holmgren J. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect Immun. 1976 Mar;13(3):735–740. doi: 10.1128/iai.13.3.735-740.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Svennerholm A. M., Wikström M., Lindblad M., Holmgren J. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med Biol. 1986;64(1):23–30. [PubMed] [Google Scholar]
  42. Svennerholm A., Lange S., Holmgren J. Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice. Infect Immun. 1978 Jul;21(1):1–6. doi: 10.1128/iai.21.1.1-6.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Vaerman J. P., Derijck-Langendries A., Rits M., Delacroix D. Neutralization of cholera toxin by rat bile secretory IgA antibodies. Immunology. 1985 Mar;54(3):601–603. [PMC free article] [PubMed] [Google Scholar]
  44. Weltzin R., Lucia-Jandris P., Michetti P., Fields B. N., Kraehenbuhl J. P., Neutra M. R. Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol. 1989 May;108(5):1673–1685. doi: 10.1083/jcb.108.5.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES